Puromycin is a potent inhibitor of protein synthesis both in vitro and in vivo.1, 2
RNA was extracted with phenol. The cells were shaken with equal volumes of water-saturated phenol and 0.02 M pH 7.2 phosphate buffer at room temperature. After centrifugation, the aqueous phase containing ribosomal RNA and transfer RNA was removed, the phenol phase was discarded, and the interphase nucleoprotein precipitate was re-extracted twice with phenol-buffer.
Phenol extraction under the above conditions of pH and ionic strength results in fractionation of mammalian cell RNA into 2 classes:10-12 the aqueous phase RNA (pRNA) containing about 90% of total cellular RNA; and the residual interphase RNA (rRNA) associated with DNA and protein precipitated at the interphase (comprising about 10% of total cellular RNA). 13 Aqueous phase pRNA was precipitated several times with ethanol, then was freed of bound contaminating radioactive compounds by 3 precipitations from 2 M potassium acetate solution, brought to 30% ethanol and chilled to -20°for 2 hr to allow precipitation." Precipitation in the cold from potassium acetate has proved to be the best method tested for removal of radioactive contaminants without breakdown of the RNA detectable by sedimentation analysis. Failure to remove tightly bound radioactivity leads to inaccurate determinations of RNA synthetic rates and sucrose sedimentation patterns, but precipitation from potassium acetate yielded RNA in which almost all radioactivity could be recovered in the separated 2', 3' nucleotides after alkaline hydrolysis.
After removing the aqueous phase and discarding the phenol phase, the nucleoprotein interphase precipitate was twice more extracted with phenol-buffer, and the nucleoprotein was washed and precipitated 3 times from 95% ethanol. DNA and rRNA were then extracted from the precipitate by adding 1.5 ml of 5% sodium lauryl sulfate solution containing 0.1 M citrate and 0.001 M EDTA, stirring for 3 min at 600, diluting with 5 ml 0.15 M NaCl, and stirring 3 additional min at 600. Finally, an equal volume of water-saturated phenol was added, and the mixture shaken vigorously for 3 min at 60°, then centrifuged, and the aqueous phase containing DNA and rRNA was removed by pipetting. DNA and rRNA were then precipitated with ethanol and reprecipitated 3 times from 2 M potassium acetate as described above for pRNA. Where only radioactivity was to be measured, carrier ribosomal RNA was added to facilitate precipitation and manipulation. Sodium lauryl sulfate treatment never released all nucleic acid from the denatured nucleoprotein interphase precipitate; but if phenol extractions were completed quickly so that 30 min or less elapsed between the first phenol treatment and addition of sodium lauryl sulfate, maximal release of DNA and rRNA was obtained. Sucrose gradient sedimentation analysis's of pRNA and rRNA was performed using the Spinco SW 39 swinging bucket head. All runs were carried out in a 5-20% linear sucrose gradient containing 0.001 M EDTA, 0.1 M NaCl, and 0.01 M tris-HCI buffer, pH 7.2. RNA was dissolved in 0.15 M NaCl and carefully layered over 4.7 ml sucrose gradients in 0.3 ml amounts.
After centrifugation at 38,000 rpm for 6 hr, 2 drop fractions were collected from the bottom of the tube and were analyzed for radioactivity and optical density and, in some cases, pooled fractions were degraded to nucleotides and base composition determined.
Base ratios were determined after electrophoretic separation of nucleotides obtained by alkaline hydrolysis of RNA. Electrophoretic separation was carried out in pH 3.5 citrate buffer using 1,200 volts for 6 hr (16 volts/cm). '6, analyzed by sedimentation in a sucrose gradient ( Fig. 1) , it was found that puromycin treatment led to inhibition of 30S and 18S ribosomal RNA synthesis, while 4-8S soluble RNA continued to be synthesized at near normal rates. The magnitude of inhibition of 30S RNA varied in different experiments, but there was consistent inhibition of ribosomal RNA synthesis and only slight inhibition of soluble RNA synthesis. Prolonged treatment with puromycin usually caused more complete inhibition of ribosomal RNA synthesis than short treatment, although in some experiments exposure to puromycin for 2 hr showed marked inhibition. Puromycin treatment had no effect on total ribosomal RNA measured spectrophotometrically, so it apparently acts by inhibiting ribosomal RNA synthesis rather than by breaking down already formed ribosomal RNA. This was confirmed by the finding that puromycin treatment of cells, labeled with P32 24 hr previously, affected neither the amount of P32 in pRNA nor the sedimentation rate or quantity of P32 in 30S or 18S ribosomal RNA.
Effect of puromycin on ribosomal precursor RNA and other rRNA: It has been demonstrated by Georgiev and co-workers,'0 and by Sibatani and colleagues,"' 12 that phenol nonextractable (r) RNA differs from the bulk of mammalian cell RNA in having a higher turnover rate and a different base composition. Hiattl4 showed that pretreatment of liver cells with sodium dodecyl sulfate was necessary to enable extraction of this rapidly labeled RNA into the aqueous phase during phenol treatment. Scherrer et al.2' have recently shown that sodium dodecyl sulfate treatment before phenol extraction of HeLa cells allows isolation of this material as large (35S and 45S) rapidly labeled RNA which appears to be ribosomal precursor RNA. We demonstrated earlier that HeLa cell rRNA differs markedly from bulk ribosomal and soluble pRNA in base composition.'3 Figure 2 shows a sucrose sedimentation diagram of P32-labeled rRNA released from a phenol interphase precipitate by sodium lauryl sulfate treatment. Radioactivity is found throughout the tube representing molecules from 50S in size to molecules smaller than 6S. Because of the difficulty in extracting rRNA from denatured protein, precipitates without appreciable breakdown sedimentation profiles differ in each run, but in every case RNA ranging in size from very large to small molecules is found. DNA is also present in these extracts but contributes negligible radioactivity under these con-ditions of labeling. All extracts are heated at 1000 for 30 sec and quickly cooled before sucrose sedimentation to avoid cosedimentation of rRNA annealed to DNA. Optical density of added HeLa cell 30S and 18S ribosomal RNA and 4-85 transfer RNA are included as references. Figure 2 also shows base ratios of pooled rRNA fractions from 3 portions of the sucrose gradient. It can be seen that the largest rRNA molecules have high guanine-cytosine base compositions corresponding to those of ribosomal RNA. This appears to be the large precursor of ribosomal RNA detected after pulse-labeling by Scherrer et al.2' However, the more slowly sedimenting rRNA molecules (up to 20S) exhibit high uracil base ratios which are not inconsistent with their being messenger RNA. As reported previously,'3 the total rRNA obtained by direct alkaline hydrolysis of the phenol interphase precipitate is also high in uracil, but this obviously includes ribosomal precursor RNA having the high G-C base ratios characteristic of ribosomal RNA. are shown. Figure 3 shows a sucrose sedimentation pattern exhibited by rRNA extracted from normal cells and an aliquot of the same cells treated 4 hr with 100 ,ugm/ml puromycin. Puromycin treatment inhibited synthesis of rapidly sedimenting ribosomal precursor RNA, leaving a broad distribution of RNA having a peak 10-20S and exhibiting very high uracil base ratios at all levels of the sucrose gradient.
Thus, puromycin arrested synthesis of ribosomal RNA and ribosomal precursor RNA, and allowed synthesis of a high uracil RNA which might be messenger RNA. The stability of this RNA was examined by labeling cells with p32 for 4.0 hr, then removing p32 medium and incubating in medium containing cold inorganic phosphate for 20 hr before extracting pRNA and rRNA. It was found that almost all label was in ribosomal and soluble RNA of the pRNA fraction and in DNA. No ribosomal precursor rRNA was detectable in sucrose gradients, and only about 10 per cent of the high uracil rRNA present 20 hr previously could be found in the 10-20S region of the gradient. This rRNA had a base composition differing (U = 32.2, G = 34.4, A = 16.0, C = 17.4) from that found before the 20 hr chase. Whether this is a population of RNA molecules that may include "stable messenger" is speculative, but it is clear that the bulk of rRNA (including both ribosomal precursor RNA and the smaller high uracil base ratio molecules) turns over within one generation time (generation time = 20-30 hr).
RNA polymerase activity of HeLa cells treated with puromycin: Since puromycin arrests ribosomal RNA synthesis of intact cells, it was of interest to determine its effect on cellular RNA polymerase activity. Table 2 shows that exposure of HeLa cells to 100 ALg/ml puromycin results in loss of less than 30 per cent of original aggregate enzyme RNA polymerase activity within 6 hr. Figure 4 shows a sucrose sedimentation diagram of the RNA produced by aggregate enzyme from normal and treated cells. In each case, a broad distribution of RNA is observed with a peak at about 15S. Either a very small proportion of ribosomal size RNA is produced by this DNA-primed RNA polymerase or it is degraded to smaller fragments during incubation in the reaction mixture. It is likely that most of the RNA produced by this DNA-enzyme aggregate is equivalent to the informational RNA of the intact cells. It is interesting therefore that it is similar in size to the high uracil rRNA synthesized by intact cells, which also may contain informational RNA. The amount of RNA polymerase activity surviving 6 hr inhibition of protein synthesis by puromycin indicates that aggregate enzyme is rather stable and does not turn over rapidly. However, the enzyme that polymerizes ribosomal RNA might turn over rapidly, and this might then contribute to the small decrease in aggregate enzyme that does result from puromycin treatment. Puromycin added to the RNA polymerase reaction mixture had no effect on in vitro RNA syn--thesis (Table 2) . Discussion.-It seems reasonable to assume that, whatever the mechanism of puromycin depression of ribosomal RNA synthesis may be, it is a secondary effect resulting from inhibition of protein synthesis by puromycin. It is possible, but not likely, that interruption of protein synthesis leads to repression of the chromosomal locus controlling ribosomal RNA synthesis. In Escherichia coli it appears that deprivation of an essential amino acid leads to repression of the ribosomal locus.22' However, in E. coli, interruption of protein synthesis by other means (by chloramphenicol) does not cause immediate repression of ribosomal RNA synthesis.6' 7 Chloramphenicol treatment prevents normal ribosome synthesis and leads to production of "CM particles" containing ribosomal RNA associated with a small amount of protein. 23 Rather than inhibiting RNA synthesis, chloramphenicol may greatly stimulate ribosomal RNA incorporation into "CM particles" in bacteria grown in minimal medium. 7 As mentioned above, the RNA polymerase for ribosomal RNA may turn over RNA Synthesized by Fig. 1 , except that the concentrations of chloramphenicol, ribo-RNA was heated at 100'C for 30 see prior somal RNA synthesis proceeds only to to sucrose sedimentation runs (to prevent cosedimentation of nascent RNA anan extent allowed by the amount of pre-nealed to template DNA). existing ribosomal protein available. Kurland and Maal0e suggest that it was only at chloramphenicol concentrations which do not completely arrest protein synthesis that sufficient "CM particle" protein was produced to allow normal or accelerated rates of ribosomal RNA synthesis.
The data presented here in several respects resembles the data of Kurland and Maaloe except that the puromycin effect on mammalian cell RNA synthesis occurs within a fraction of the one day generation time, whereas there is little chloramphenicol depression of E. coli RNA synthesis before several generation times have elapsed. Takeda The present study confirms the report of Tamaoki and Mueller9 that puromycin inhibits ribosomal RNA synthesis. However, they reported continued synthesis of ribosomal precursor RNA after puromycin treatment and they suggested that puromycin acts not by inhibiting polymerization of ribosomal precursor, but by preventing maturation of polymerized ribosomal precursor to 16S and 28S ribosomal RNA molecules. Following the longer periods of puromycin arrest of protein synthesis employed in the present study, it appeared that continuing protein synthesis is required for polymerization of the large ribosomal precursor molecules. Attempts to study these effects in a cell-free system are in progress.
Summary.-Puromycin at a concentration of 100 /hg/ml inhibits synthesis of HeLa cell ribosomal RNA, but only slightly inhibits soluble RNA synthesis. Both high molecular weight ribosomal precursor RNA and a smaller rapidly labeled RNA resembling messenger RNA can be separated from ribosomal RNA and transfer RNA by phenol fractionation and detergent treatment of phenol-precipitated nucleoprotein. Puromycin inhibits ribosomal precursor RNA synthesis but does not inhibit synthesis of the smaller rapidly labeled fraction. Thus, phenol fractionation of puromycin-treated cells allowed isolation and sedimentation analysis of this labile RNA which has base ratios very different from that of ribosomal and transfer RNA.
Puromycin inhibition of HeLa cell protein synthesis for 6 hr caused less than 30 per cent inhibition of DNA-primed aggregate enzyme RNA polymerase, indicating that most of the RNA polymerase of HeLa cells is quite stable. However, the decrease that did occur might be enough to account for loss of a separate polymerase concerned with ribosomal RNA synthesis.
RNA produced by DNA-primed aggregate enzyme RNA polymerase from HeLa cells had a broad size distribution with a peak at about 15S. This RNA was similar in size to the rapidly labeled RNA found in the phenol-nonextractable fraction of puromycin-treated HeLa cells.
